Skip to content
healthcare.dev

Cilostazol

NDC 0093-2064, Cilostazol, tablet, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-2064
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077027
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-2064 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CILOSTAZOL100 mg/1

Pharmacologic classes

Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]

Package NDCNDC-11Package
0093-2064-060009320640660 TABLET in 1 BOTTLE (0093-2064-06)
0093-2064-50000932064505000 TABLET in 1 BOTTLE (0093-2064-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a6292311-9cb2-49ff-b8bf-12e2dbd196cd
  • NADAC price for package 00093206406

    GET /v1/drugs/nadac/00093206406
  • NADAC price for package 00093206450

    GET /v1/drugs/nadac/00093206450

Use it

Look up 0093-2064 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-2064 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-2064. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.